Olink

Olink®
Part of Thermo Fisher Scientific

Plasma mitochondrial-associated proteins scale with illness severity and predict outcome in suspected sepsis

Critical Care, 2026

Meems C., van Beuningen F., Coenen B., Lu J., Ter Horst S., Bouma H.

Disease areaApplication areaSample typeProducts
Immunological & Inflammatory Diseases
Patient Stratification
Plasma
Olink Explore HT

Olink Explore HT

Abstract

Background
Mitochondrial dysfunction has been implicated in sepsis-related organ failure. We investigated whether plasma profiles of mitochondrial-associated proteins are associated with illness severity and short-term outcomes and explored whether they reveal distinct mitochondrial subphenotypes.

Methods
In this post hoc analysis of the Acutelines data-biobank, we included 213 adult patients presenting to the emergency department with a suspicion of sepsis, with infection confirmed by independent adjudication. Blood plasma proteins of patients were quantified with the Olink Explore HT platform; of 5,416 proteins, 232 mitochondrial-associated proteins (MitoCarta3.0) were z-standardized and averaged per patient to derive a continuous mitochondrial-protein score. To explore whether operationally distinct patient groups could be identified along this gradient, we additionally performed principal component analysis with K-means clustering on the same protein set. Differential abundance analysis, pathway enrichment, and least absolute shrinkage and selection operator regression were performed as exploratory analyses.

Results
The continuous mitochondrial-associated protein score increased with illness severity (Spearman ρ 0.18–0.29; p < 0.01) and worse 72-hour outcomes (odds ratio per standard deviation: organ failure-free survival 0.57; intensive care unit admission 1.66; mortality 2.36). Exploratory clustering identified two groups differing mainly in overall mitochondrial-associated protein abundance. Considerable overlap and limited support for a discrete two-cluster structure suggested variation along a continuum rather than clearly distinct mitochondrial subphenotypes. Exploratory pathway analyses implicated mitochondrial metabolism, cellular stress, and injury-related processes.ConclusionsHigher plasma mitochondrial-associated protein abundance was associated with greater illness severity and worse short-term outcomes in suspected sepsis. These associations are hypothesis-generating, providing a first step toward understanding the role of mitochondrial dysfunction in sepsis severity.

Read publication ↗